Lilly, the pharmaceutical giant, would love for you to believe that tirzepatide is the silver bullet we've all been waiting for — slashing your diabetes risk by 94% while you shed pounds. But dig a ...
Obesity is a chronic disease that results in substantial global morbidity and mortality. The efficacy and safety of tirzepatide, a novel glucose-dependent insulinotropic polypeptide and glucagon-like ...